Head and Neck Squamous Cell Carcinoma (HNSCC) Recruiting Phase 2 Trials for DB12117 (Mitometh)

Also known as: Head and Neck Squamous Cell Carcinoma

IndicationStatusPhase
DBCOND0043665 (Head and Neck Squamous Cell Carcinoma (HNSCC))Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02270814Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell CarcinomaTreatment
NCT02734537Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck Who Have Undergone SurgeryTreatment